# Rossari Biotech to acquire Tristar Intermediates for INR120 crore

Rossari Biotech Limited announced the acquisition of 100% equity of Tristar Intermediates Pvt. Ltd. for an enterprise value of INR120 crore. The deal includes 76% upfront and 24% over three years, funded from cash on balance sheet.

- Type: Acquisition
- Announced: 2021-07-17
- Where: Thane, Maharashtra, India
- Value: $16.0M (1.20B INR)
- Status: announced
- Capacity: 15,000 MTPA
- Products: preservatives, aroma chemicals, home and personal care additives
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Rossari Biotech](https://endata.com/companies/48810.md) (acquirer)
- [Tristar Intermediates](https://endata.com/companies/56528.md) (target)

## Sources

- [rossari.com](https://www.rossari.com/acquisition-trio-tristar-unitop/), 2021-07-17: "Rossari Biotech Limited today announced that its Board of Directors has approved the acquisition of Tristar Intermediates Pvt. Ltd."
- [business-standard.com](https://www.business-standard.com/article/companies/rossari-to-acquire-tristar-intermediates-at-enterprise-value-of-rs-120-cr-121071800624_1.html), 2021-07-18: "The combined capabilities will provide a strong growth momentum and will enable us to expand further into the high-potential product categories of personal care and home care"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.